{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:11:49Z","timestamp":1790367109190,"version":"4.1.0"},"reference-count":25,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.13196","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T17:01:34Z","timestamp":1600275694000},"page":"e2013196","source":"Crossref","is-referenced-by-count":43,"title":["Assessment of Placebo Response in Objective and Subjective Outcome Measures in Rheumatoid Arthritis Clinical Trials"],"prefix":"10.1001","volume":"3","author":[{"given":"Jan","family":"Vollert","sequence":"first","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Pain Research, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy R.","family":"Cook","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted J.","family":"Kaptchuk","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv T.","family":"Sehra","sequence":"additional","affiliation":[{"name":"Mount Auburn Hospital, Harvard Medical School, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre K.","family":"Tobias","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn T.","family":"Hall","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,9,16]]},"reference":[{"issue":"9715","key":"zoi200497r1","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S0140-6736(09)61706-2","article-title":"Biological, clinical, and ethical advances of placebo effects.","volume":"375","author":"Finniss","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"zoi200497r3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1056\/NEJMp1504023","article-title":"Placebo effects in medicine.","volume":"373","author":"Kaptchuk","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi200497r4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/mus.v56.3","article-title":"Placebo response in pain, fatigue, and performance: possible implications for neuromuscular disorders.","volume":"56","author":"Shaibani","year":"2017","journal-title":"Muscle Nerve"},{"issue":"3","key":"zoi200497r5","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/nmo.2005.17.issue-3","article-title":"The placebo effect in irritable bowel syndrome trials: a meta-analysis.","volume":"17","author":"Patel","year":"2005","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"zoi200497r6","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1038\/s41598-018-20993-y","article-title":"Open-label placebo treatment for cancer-related fatigue: a randomized-controlled clinical trial.","volume":"8","author":"Hoenemeyer","year":"2018","journal-title":"Sci Rep"},{"issue":"4","key":"zoi200497r7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.5811\/westjem.2018.4.38383","article-title":"Understanding the use of composite endpoints in clinical trials.","volume":"19","author":"McCoy","year":"2018","journal-title":"West J Emerg Med"},{"issue":"2","key":"zoi200497r8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/(ISSN)1529-0131","article-title":"A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response.","volume":"57","author":"American College of Rheumatology Committee to Reevaluate Improvement Criteria","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"9","key":"zoi200497r9","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1136\/ard.2009.119933","article-title":"Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab\u2019s Efficacy in MTX Inadequate Responders (SERENE).","volume":"69","author":"Emery","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"zoi200497r10","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1002\/art.v58:11","article-title":"Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.","volume":"58","author":"Keystone","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"zoi200497r11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/ard.2008.101659","article-title":"Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study, a randomised controlled trial.","volume":"68","author":"Smolen","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"zoi200497r12","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1136\/annrheumdis-2013-204632","article-title":"Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial.","volume":"74","author":"Smolen","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"zoi200497r13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/annrheumdis-2011-200170","article-title":"Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE.","volume":"71","author":"Tak","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"zoi200497r14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/sim.v26:2","article-title":"Revisiting the relation between change and initial value: a review and evaluation.","volume":"26","author":"Tu","year":"2007","journal-title":"Stat Med"},{"key":"zoi200497r15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.biopha.2017.05.055","article-title":"Rheumatoid arthritis: recent advances on its etiology, role of cytokines and pharmacotherapy.","volume":"92","author":"Alam","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"zoi200497r16","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1002\/art.v64.6","article-title":"Learning about the natural history of rheumatoid arthritis development through prospective study of subjects at high risk of rheumatoid arthritis-related autoimmunity.","volume":"64","author":"Deane","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"7","key":"zoi200497r17","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.clinthera.2019.04.028","article-title":"The natural history of rheumatoid arthritis.","volume":"41","author":"Deane","year":"2019","journal-title":"Clin Ther"},{"issue":"1","key":"zoi200497r18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0889-857X(21)00171-X","article-title":"What is the natural history of rheumatoid arthritis?","volume":"19","author":"Pincus","year":"1993","journal-title":"Rheum Dis Clin North Am"},{"issue":"9","key":"zoi200497r19","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1097\/j.pain.0000000000000217","article-title":"Predictors of the placebo analgesia response in randomized controlled trials of chronic pain: a meta-analysis of the individual data from nine industrially sponsored trials.","volume":"156","author":"Vase","year":"2015","journal-title":"Pain"},{"issue":"1","key":"zoi200497r20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3899\/jrheum.190008","article-title":"Placebo response in rheumatoid arthritis clinical trials.","volume":"47","author":"Bechman","year":"2020","journal-title":"J Rheumatol"},{"issue":"5","key":"zoi200497r21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.7326\/M15-0623","article-title":"Effectiveness and implications of alternative placebo treatments: a systematic review and network meta-analysis of osteoarthritis trials.","volume":"163","author":"Bannuru","year":"2015","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi200497r22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/ije\/dyh299","article-title":"Regression to the mean: what it is and how to deal with it.","volume":"34","author":"Barnett","year":"2005","journal-title":"Int J Epidemiol"},{"issue":"2","key":"zoi200497r23","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/ajcn\/nqz196","article-title":"Best (but oft-forgotten) practices: identifying and accounting for regression to the mean in nutrition and obesity research.","volume":"111","author":"Thomas","year":"2020","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"zoi200497r24","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/cpt.2019.105.issue-4","article-title":"Efficacy and effectiveness too trials: clinical trial designs to generate evidence on efficacy and on effectiveness in wide practice.","volume":"105","author":"Selker","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"zoi200497r2","volume-title":"Rare Diseases: Natural History Studies for Drug Development: Guidance for Industry","author":"US Food and Drug Administration, US Dept of Health and Human Services","year":"2019"},{"key":"zoi200497r25","volume-title":"Individual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data Sharing","author":"Kuntz","year":"2019"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2770651\/vollert_2020_oi_200497_1599661895.46626.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T17:36:50Z","timestamp":1668793010000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2770651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,16]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.13196","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,16]]}}}